ARCHIVES

Arsenic Compound Improves Survival Of Adults With APL

This article is from The Cancer Letter archive.

Vol. 30 No. 2 | February 23, 2007

Download PDF Visit The Full Archive

Related Articles

In Brief: General Motors Cancer Research Foundation Prizewinners: Brock, Li, Fraumeni, Harlow

June 16, 1995

In Brief: Norman Sharpless Named Director of UNC Lineberger

September 6, 2013

FDA Says Bristol’s UFT “Not Approvable” For Colorectal Cancer, Contrary To ODAC.

March 30, 2001

Benefit Of Chemotherapy Depends ER Status

April 28, 2006

Health Organizations: ACS Statement Supports funding of Research On Human Stem cells

December 17, 1999

Cancer Meetings For May, June, Future

April 27, 1990